These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6137048)

  • 41. [Correlation between adhesive factors of primary hemostasis and liver fibrogenesis in alcoholic live cirrhosis].
    Udvardy M; Hársfalvi J; Pósán E; Káplár M; Katona E; Rák K
    Orv Hetil; 1994 Mar; 135(10):523-6. PubMed ID: 8146008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Protective effect of colchicine on tissue damage caused by free radicals in hepatic cirrhosis: an experimental study in rats].
    Rhoden EL; Mauri M; Petteffi L; Belló-Klein A; Zettler CG; Rhoden CR
    Arq Gastroenterol; 1997; 34(2):91-6. PubMed ID: 9496424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
    Parés A; Rodés J
    Gastroenterol Hepatol; 1996 Feb; 19(2):58-67. PubMed ID: 8616682
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment with zincum metallicum CH5 in patients with liver cirrhosis. Preliminary study.
    Bădulici S; Chirulescu Z; Chirilă P; Chirilă M; Roşca A
    Rom J Intern Med; 1994; 32(3):215-9. PubMed ID: 7866338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-inflammatory and immunosuppressive treatment of alcoholic liver disease.
    Juhl E; Christensen E
    Acta Med Scand Suppl; 1985; 703():195-9. PubMed ID: 3867241
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of colchicine and steroids in the treatment of alcoholic liver disease.
    Galambos JT; Riepe SP
    Recent Dev Alcohol; 1984; 2():181-94. PubMed ID: 6374780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis.
    Akriviadis EA; Steindel H; Pinto PC; Fong TL; Kanel G; Reynolds TB; Gupta S
    Gastroenterology; 1990 Sep; 99(3):811-8. PubMed ID: 2199290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative study of results of hepatic transplantation between 2 groups of patients: alcoholic cirrhosis versus non-alcoholic cirrhosis].
    Jaeck D; Fratte S; Boudjema K; Ellero B; Woehl-Jaegle ML; Vanlemmens C; Altier M; Duclos B; Vetter D; Bachellier P
    Chirurgie; 1993-1994; 119(9):569-73. PubMed ID: 7729207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New therapies in hepatitis C virus and chronic liver disease: antifibrotics.
    Rockey DC
    Clin Liver Dis; 2006 Nov; 10(4):881-900. PubMed ID: 17164123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Reversibility of advanced liver fibrosis--therapeutic possibility and biochemical monitoring of the disease].
    Lebensztejn DM
    Przegl Epidemiol; 2005; 59(2):535-40. PubMed ID: 16190564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current aspects of therapy of primary biliary cirrhosis].
    Grassi M; Manzi P; Schiffino L; Raffa S
    Clin Ter; 1997 Mar; 148(3):95-104. PubMed ID: 9377846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytosine arabinoside in herpes zoster.
    Rojkind M; Uribe M; Kershenobich D
    Lancet; 1973 Jan; 1(7793):38-9. PubMed ID: 4118555
    [No Abstract]   [Full Text] [Related]  

  • 53. Colchicine, serum albumin, and alkaline phosphatase.
    Kershenobich D; Uribe M; Suarez GI; Tamayo RP; Rojkind M
    Ann Intern Med; 1978 Jul; 89(1):144. PubMed ID: 352218
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
    Lee YM; Kaplan MM
    Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of acute alcoholic alcoholism].
    Michel H; Larrey D; Blanc P
    Ann Gastroenterol Hepatol (Paris); 1993; 29(1):29-39. PubMed ID: 7680191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spironolactone and enzyme induction in patients with alcoholic cirrhosis.
    Miguet JP; Vuitton D; Thebault-Lucas A; Joanne C; Dhumeaux D
    Gastroenterology; 1980 May; 78(5 Pt 1):996-1000. PubMed ID: 7380205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pattern of serum amino acids in patients with liver cirrhosis. Influence of shunt surgery and transesophageal sclerotherapy.
    Joelsson B; Hultberg B; Alwmark A; Gullstrand P; Bengmark S
    Scand J Gastroenterol; 1984 Jun; 19(4):547-51. PubMed ID: 6611579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis.
    Wensing G; Hoffmann K; Heidemann HT
    Z Gastroenterol; 1993 Jan; 31(1):15-9. PubMed ID: 8447150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
    Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
    Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alcohol-related liver disease: treatment controversies.
    Batey RG
    Alcohol Alcohol Suppl; 1994; 2():327-33. PubMed ID: 8974352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.